Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B | Zendy

Chengzhong Li | Zendy; Jingjing Hu | Zendy; Jianya Xue | Zendy; Wei Yin | Zendy; Yayun Liu | Zendy; Wenhan Fan | Zendy; Hao Xu | Zendy; Xue-Song Liang | Zendy

Open Access

Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B

Author(s) -

Chengzhong Li,

Jingjing Hu,

Jianya Xue,

Wei Yin,

Yayun Liu,

Wenhan Fan,

Hao Xu,

Xue-Song Liang

Publication year - 2014

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v20.i28.9486

Subject(s) - telbivudine , lamivudine , hbeag , medicine , immunology , cd8 , hepatitis b virus , nucleoside analogue , hepatitis b , cellular immunity , gastroenterology , virology , hbsag , immune system , virus , nucleoside , biology , biochemistry

To determine the relationship between host immunity and the characteristics of viral infection or nucleoside analogues (NAs) themselves in patients with chronic hepatitis B (CHB) receiving NA therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research